Healthcare -
Biotechnology - NASDAQ - NL
$ 0.94
0.0639 %
$ 24.7 M
Market Cap
-0.93
P/E
Price Target
Average
538.30%
Revenue Forecast
Estimate
54.78%
EBIT
Estimate
29.65%
Net Income
Estimate
33.79%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
LAVA Therapeutics N.V.
Wall Street analysts predict an average 1-year price target for LVTX of $6 , with forecasts ranging from
a
low of
$6 to a high of $6 .
LVTX Lowest Price Target
Wall Street Target
6 USD
538.30%
LVTX Average Price Target
Wall Street Target
6 USD
538.30%
LVTX Highest Price Target
Wall Street Target
6 USD
538.30%
REVENUE FORECAST
Revenue Forecast Chart LVTX
EBIT FORECAST
EBIT Forecast Chart LVTX
NET INCOME FORECAST
Net Income Chart LVTX